Rac1-regulated endothelial radiation response stimulates extravasation and metastasis that can be blocked by HMG-CoA reductase inhibitors.
Radiotherapy (RT) plays a key role in cancer treatment. Although the benefit of ionizing radiation (IR) is well established, some findings raise the possibility that irradiation of the primary tumor not only triggers a killing response but also increases the metastatic potential of surviving tumor c...
Guardado en:
Autores principales: | Melanie Hamalukic, Johannes Huelsenbeck, Arno Schad, Stefan Wirtz, Bernd Kaina, Gerhard Fritz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c2e52461860349a28e44f53b3579f5a2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
por: Shi-You Jiang, et al.
Publicado: (2018) -
Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients.
por: Richard D Moore, et al.
Publicado: (2011) -
Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of HMG CoA reductase and UBIAD1
por: Rania Elsabrouty, et al.
Publicado: (2021) -
Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations.
por: Minky Son, et al.
Publicado: (2013) -
HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study.
por: Rita Bergqvist, et al.
Publicado: (2021)